Select Cognition Coverage and Published Editorials
Their Alzheimer’s treatment worked — but shares fell anyway
PharmaVoice
By Michael Gibney
Aug. 29, 2024
Small molecule oligomer antagonist for Alzheimer’s disease boosts brain connectivity
Healio Neurology
By Shenaz Bagha
August 27, 2024
CT1812 slows cognitive decline in proof-of-concept clinical trial
Alzheimer’s News Today
By Marisa Wexler
August 23, 2024
Cognition Stays the Course
GEN Edge
By Alex Philippidis
August 2, 2024
Supportive Evidence for CT1812 as Treatment for Alzheimer Disease
Neurology Live
By Marco Meglio
August 3, 2024
Amyloid Remains a Key Target in Next-Generation Alzheimer’s Treatments
BioSpace
By Kate Goodwin
June 10, 2024